In Moscow, Russia, February 27 – 28 the 46th SCIENTIFIC SESSION: “GENETICS IN GASTROENTEROLOGY: POSSIBILITIES AND PERSPECTIVES”, organized by the Central Institute for Research on Gastroenterology took place.
Director of the Institute of Clinical and Preventive medicine of University of Latvia Marcis Leja gave two lectures at the conference on topics of prevention of inherited gastrointestinal tumors and gastric cancer.
In a lecture on stomach cancer, M.Leja talked about VOGAS project, as well as on other volatile marker diagnostic projects to detect gastric cancer.
Further possibilities for cooperation with leading Russian gastroenterology experts were discussed, incl. opportunities to submit joint projects.
On February 6, a scientific-practical conference on the different aspects of gastric cancer “Stomach Cancer – A to Z” was held at Pavlov First Saint Petersburg State Medical University. The conference was attended by leading oncologists and management from St. Petersburg University, and practitioners from hospitals and outpatient clinics in the region.
The keynote presentation of the conference on the epidemiology and screening capabilities of gastric cancer was given by director of Institute of Clinical and Preventive Medicine of the University of Latvia, professor M.Leja.
In his lecture, M.Leja focused on the diagnostic capabilities of volatile markers, currently underway in the VOGAS project.
The annual H2020 VOGAS project working meeting takes place in See, Austria, January 26 – 31. During the meeting project progress and future project plans are discussed.
From Institute of Clinical and Preventive Medicine of the University of Latvia the meeting is represented by Director of the institute prof. Mārcis Leja and PhD student Linda Mežmale.
VOGAS project – “Screening of Gastric Cancer via Breath volatile organic compunds by Hybrid Sensing Approach”.
The aim of the VOGAS H2020 project is to clarify the sources of volatile markers, to perform the clinical approbation of the latest generation stationary breath analyzer for early diagnosis of cancer. Using the latest generation of stationary breath analyzers to detect volatile markers, take part in an international stomach cancer screening program to improve this non-invasive method of for diagnosis of cancer.
6-8, 2020, Shenzhen, China. The 1st
Symposium on Million Microbiome of Human Project (MMHP) took place in the China
National GeneBank. This is an ambitious and unique project aiming to draw human
microbial maps of different races, ages, genders and health conditions based on
at least 1 mil. metagenome analysis.
Involvement of research institutions from all over the world is anticipated. It has been planned that samples from Latvian inhabitants that have either already been donated for the VOGAS project realization or will be collected in the future within this study, will be an important part for MMHP and will allow either to characterize the human microbiome population in Latvia or to stimulate research in this field in the country.
The 14th International conference “Astana-Gastro-2019” was taking place in Nur-Sultan, Kazakhstan, November 1-2, 2019. Marcis Leja (Institute of Clinical and Preventive Medicine, University of Latvia) was presenting a lecture on gastric cancer screening. The presentation was containing information on the questionnaire results that was conducted within the projects Sniffphone and VOGAS.
Project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986
On October 24 – 25 a working meeting of the H2020 project VOGAS was held at Ulm University in Germany. During the meeting both technological development issues and planned clinical trials in European and Latin American countries were discussed.
These clinical trials are coordinated by Institute of Clinical and Preventive Medicine of the University of Latvia
On September 26 – 27 a seminar on responsible research in clinical trials was organized by partners of the Horizon 2020 VOGAS project. The partners discussed various aspects of the applicability of the new diagnostic approach, interviewed physicians and nurses to find out how healthcare professionals experience similar systems, and analyzed best practices for obtaining information from potential users worldwide. The seminar was organized by project partners – Institute of clinical and preventive medicine of the University of Latvia in collaboration with VTT (Technical Research Center of Finland), with participation of Technion (Israel Institute of Technology) and National Cancer Institute of Ukraine (NCIU).
The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986
The 11th International ICAPS conference: Cancer Prevention by Targeting Infection, Inflammation and the Immune System was was taking place in London, UK, on September 9-10. Scientific leader of the VOGAS project M.Leja was participating with an inivited lecture entitled “H. pylori Eradication for Gastric Cancer Prevention”. The results of the Sniffphone/VOGAS survey of specialists were demonstrated during the presentation. Conference is organized by The International Cancer Prevention Society (ICAPS) and the UK Therapeutic Cancer Prevention Network (UKTCPN).
At the European Helicobacter and Microbiota Study Group XXXII International Workshop, which took place in Innsbruck, Austria, from 5 to 7 September, The VOGAS project was represented by a poster presentation (the first author Reinis Vangravs) “VOC emission sampling from Helicobacter pylori cultures”.